The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660 Robert Orenstein Commentary Open access 07 November 2022 Pages: 1 - 7
The Value of Rotavirus Vaccination in Europe: A Call for Action Robert CohenFederico Martinón-TorresDirk Poelaert Commentary Open access 10 November 2022 Pages: 9 - 29
Publisher Correction: The Value of Rotavirus Vaccination in Europe: A Call for Action Robert CohenFederico Martinón-TorresDirk Poelaert Publisher Correction Open access 10 December 2022 Pages: 31 - 32
Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review Myriam DrysdaleLionel TanHema Sharma Review Open access 15 November 2022 Pages: 33 - 51
Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review Yuting DiaoJuan TangChunfang You Review Open access 27 November 2022 Pages: 53 - 66
Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis Yani KeKaihan WuShan Liu Review Open access 28 November 2022 Pages: 67 - 80
Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature Selim BadurOnur OzudogruAdriana Guzman-Holst Review Open access 03 December 2022 Pages: 81 - 93
Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System Lauren F. McDanielMelissa N. WhiteNathan A. Everson Original Research Open access 19 July 2022 Pages: 95 - 107
Correction to: Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System Lauren F. McDanielMelissa N. WhiteNathan A. Everson Correction Open access 02 December 2022 Pages: 109 - 110
Machine Learning Successfully Detects Patients with COVID-19 Prior to PCR Results and Predicts Their Survival Based on Standard Laboratory Parameters in an Observational Study Filip StyrzynskiDamir ZhakparovKatja Baerenfaller Original Research Open access 04 November 2022 Pages: 111 - 129
Epidemiology of Herpes Zoster in Adults in Mexico: A Retrospective Database Analysis Adriana Guzman-HolstMaria Yolanda Cervantes-ApolinarGloria Huerta-Garcia Original Research Open access 08 November 2022 Pages: 131 - 141
Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016–2019) Marta Corcuera-MunguiaRuth Gil-PrietoAngel Gil-de-Miguel Original Research Open access 08 November 2022 Pages: 143 - 156
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain Federico Martinón-TorresÁngel Gil de MiguelLuis Lizán Original Research Open access 11 November 2022 Pages: 157 - 175
Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19 Imke KirsteSayuri HortschSimon Jochum Original Research Open access 15 November 2022 Pages: 177 - 191
Ceftolozane–Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment Kosuke YoshimuraHiroki OhgeShinya Takahashi Original Research Open access 24 November 2022 Pages: 193 - 207
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer Denise Marie A. FranciscoLiangliang ZhangPablo C. Okhuysen Original Research Open access 28 November 2022 Pages: 209 - 225
Association Between Body Mass Index Variation and Early Mortality Among 834 Ethiopian Adults Living with HIV on ART: A Joint Modelling Approach Animut AlebelDavid SibbrittDaniel Demant Original Research Open access 28 November 2022 Pages: 227 - 244
Efficacy of Efavirenz-Based Regimen in Antiretroviral-Naïve Patients with HIV-1 V179D/E Mutations in Shanghai, China Zhenyan WangMin ZhangHongzhou Lu Original Research Open access 28 November 2022 Pages: 245 - 255
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience Giusy TiseoChiara BarbieriMarco Falcone Original Research Open access 28 November 2022 Pages: 257 - 271
Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study Natàlia PallarèsCristian Tebéthe MetroSud and Divine study groups Original Research Open access 10 December 2022 Pages: 273 - 289
Letter to the Editor Regarding “Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age” Kristen FeemsterThomas Weiss Letter Open access 14 November 2022 Pages: 291 - 294
A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’ Mark H. RozenbaumJohnna PerdrizetRaymond A. Farkouh Letter Open access 14 November 2022 Pages: 295 - 298
Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia Shun ItoMasahiro BannoYuji Okazaki Letter Open access 22 November 2022 Pages: 299 - 300
Response to “Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia” Flavio Mantelli Letter Open access 22 November 2022 Pages: 301 - 302